Supriya Life Sciences is trading 1.51% upper at Rs 635.80 as compared to its last closing price. Supriya Life Sciences has been trading in the price range of 647.80 & 612.00. Supriya Life Sciences has given -15.16% in this year & -7.96% in the last 5 days. Supriya Life Sciences has TTM P/E ratio 34.15 as compared to the sector P/E of 25.75.There are 1 analysts who have initiated coverage on Supriya Life Sciences. There are 1 analysts who have given it a strong buy rating & 0.00 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 46.78 Crores in its last quarter.Listed peers of Supriya Life Sciences include Shilpa Medicare (2.89%), Strides Pharma Science (1.48%), Supriya Life Sciences (1.51%).The Mutual Fund holding in Supriya Life Sciences was at 0.67% in 31 Dec 2024. The MF holding has increased from the last quarter. The FII holding in Supriya Life Sciences was at 6.52% in 31 Dec 2024. The FII holding has increased from the last quarter.
Updated on Feb 19, 2025, 07:41 PM UTC
|
|
|
|
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
---|---|---|---|---|---|---|---|---|
Shilpa Medicare | Bearish | 656.30 | 2.89 | 6,400.86 | 205.63 | 3.18 | - | 31.04 |
Strides Pharma Science | Bearish | 639.60 | 1.48 | 5,881.87 | - | 2.68 | 0.40 | 34.96 |
Supriya Life Sciences | Moderately Bearish | 635.80 | 1.51 | 5,106.53 | 41.79 | 6.35 | 0.12 | 0.62 |
Orchid Pharma | Bearish | 834.65 | 1.99 | 4,227.54 | 44.51 | 3.68 | - | 10.33 |
Hikal | Bearish | 347.45 | 0.59 | 4,285.88 | 61.58 | 3.6 | 0.35 | 35.83 |
Meeting Date | Purpose |
---|---|
2025-01-24 | Quarterly Results & Others |
2024-10-28 | Quarterly Results |
2024-08-10 | Quarterly Results |
2024-05-28 | Audited Results & Final Dividend |
2024-02-07 | Quarterly Results |
Supriya Life Sciences is trading at 635.80 as on Wed Feb 19 2025 10:12:10. This is 1.51% upper as compared to its previous closing price of 626.35.
The market capitalization of Supriya Life Sciences is 5106.53 Cr as on Wed Feb 19 2025 10:12:10.
The average broker rating on Supriya Life Sciences is Strong Buy. The breakup of analyst rating is given below -
The 52 wk high for Supriya Life Sciences is 835.35 whereas the 52 wk low is 304.05
Supriya Life Sciences can be analyzed on the following key metrics -
Supriya Life Sciences reported a net profit of 119.11 Cr in 2024.
The Mutual Fund Shareholding was 0.67% at the end of 31 Dec 2024.